Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Explore which dividend ETFs deliver the lowest tax impact while preserving dividend exposure. Assess tax treatment, distributions, and planning strategies.
21,927 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Microsoft shares fell Tuesday as investors reassessed the cost of OpenAI bets and growing capital needs, even after a...
Markets react to hints of a possible iran open deal, sparking optimism in equities and relief in energy prices. This ...
Pinterest faces headwinds after a price-target cut to $27. This story outlines three critical steps that could unlock...
Micron’s stock is dropping amid questions about whether Google's new AI memory efficiency could curb DRAM demand. Her...
Fears about a recession can shake even seasoned investors. This article unpacks this warren buffett's golden rule and...
Alphabet outpaced Amazon over the past decade in total returns, turning a $1,000 stake into roughly $7,759 vs Amazon’...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
When a tech giant like Micron dips after a rally, investors face a simple question: should micron? In this guide, we ...
Netflix unveiled a broad price increase across every U.S. tier, with an 11% average lift. JPMorgan says the move coul...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
Argan stock ascended today as investors cheered stronger profits and a brighter outlook for energy infrastructure tie...